Nasus Pharma is trading at $3.50 (up 6.1%) in after-hours sessions, extending a multi-day rally driven by broader market strength and thin liquidity.
- The move appears tied to strong risk-on sentiment as major U.S. indices rally sharply, with no fresh company-specific news or earnings reported after the close.
- The stock previously gained 5.4% during regular hours on August 4, tracking the upward momentum of the broader market.
- Price action may be amplified by typical after-hours liquidity constraints following the recent multi-day advance.